• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number FX-410560
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 02/15/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Device evaluation: "analysis of the returned device identified: underweight, missing shell (50-75%) and broken shell.A visual and microscopic analysis was performed which identified: sharp broken on radius.A dimension measurement in the shell was performed which identify the thickness within specification.Base on the device analysis the final assessment is: -sharp broken on radius assessed as an unidentified (tear) opening.-missing shell assessed as inconclusive." further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: anxiety allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to (b)(4) has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.
 
Event or Problem Description
Healthcare professional reported, left-side exchange from textured to smooth due to concern with the product.Later, patient's husband reported on behalf of the patient, left-side rupture identified upon explant surgery.The device has been explanted and replaced with non-allergan devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key15700085
Report Number9617229-2022-20484
Device Sequence Number6174761
Product Code FTR
UDI-Device Identifier10888628003019
UDI-Public10888628003019
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P040046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2021
Reporter Type Manufacturer
Report Source Consumer,Health Professional
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 10/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/17/2020
Device Model NumberFX-410560
Device Catalogue NumberFX-410560
Device Lot Number2804968
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/17/2021
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/17/2021
Initial Report FDA Received Date10/31/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/17/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age54 YR
Patient SexFemale
-
-